Book your free demo and find out what else Mya 4 from Radleys can do
Subscribe to this podcast series
First two modified T-Cell cancer therapies approved in the EU, but prices may be prohibitive for public health systems
Pricing is a complex issue - how can we make it clearer?
Counting the cost of regulation is more than a numbers game
Novartis’ drug will not routinely be available on the UK health service
© Royal Society of Chemistry Registered charity number: 207890
Site powered by Webvision Cloud